Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

Christine A. Poon

At a glance: Christine A. Poon is Director at Regeneron Pharmaceuticals (REGN). Their latest SEC Form 4, filed Nov 4, 2026, reported a sale of $211K. On file: 0 purchase lines ($0) and 12 sale lines ($11.8M).

Disclosed holdings: about $4.9M of REGN stock: 5,219 shares reported on their latest Form 4 (filed Nov 4, 2026), valued at the Nov 19, 2026 close of $932.53. This counts only REGN shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.

Director at Regeneron Pharmaceuticals, Inc. (REGN)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $11.8M

Christine A. Poon's InsiderPrint

12 trades from SEC Form 4 filings, 2025 to 2026, drawn as one fingerprint.

InsiderPrint of Christine A. Poon: 12 trades, 2025 to 20262025: 0 buys, 6 sales2026: 0 buys, 6 sales

Reading this print: Almost only sells, trading about 12 times a year, typically $747K a trade; trades in the same month most years.

  • Bump outward: a purchase (0)
  • Dent inward: a sale (12)
  • One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.

Insiders with a similar print

  1. Deepak NayarSvp & Gm Electronics Business · LFUS · 100% match
  2. Robert J. Pagano Jr.CEO, President · WTS · 100% match
  3. DST Managers VI Ltd10% Owner · CHYM · 100% match
  4. Andrew M. SapersteinPresident · MS · 100% match
  5. Andrew ReesCEO · CROX · 99% match

Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.

Reported trades

Filed Stock Type Shares Price Value Since
Nov 4SEC REGNRegeneron Pharmaceuticals, Inc. Sell 21812,831 held (−2%) $966.74 $211K -3.5%
Nov 4SEC REGNRegeneron Pharmaceuticals, Inc. Sell 77212,059 held (−6%) $967.38 $747K -3.6%
Nov 4SEC REGNRegeneron Pharmaceuticals, Inc. Sell 2,4999,560 held (−21%) $968.58 $2.4M -3.7%
Nov 4SEC REGNRegeneron Pharmaceuticals, Inc. Sell 3,2036,357 held (−34%) $969.50 $3.1M -3.8%
Nov 4SEC REGNRegeneron Pharmaceuticals, Inc. Sell 9375,420 held (−15%) $970.51 $909K -3.9%
Nov 4SEC REGNRegeneron Pharmaceuticals, Inc. Sell 2015,219 held (−4%) $971.31 $195K -4.0%
Oct 31SEC REGNRegeneron Pharmaceuticals, Inc. Sell 6508,202 held (−7%) $652.68 $424K +42.9%
Oct 31SEC REGNRegeneron Pharmaceuticals, Inc. Sell 2,7355,467 held (−33%) $653.50 $1.8M +42.7%
Oct 31SEC REGNRegeneron Pharmaceuticals, Inc. Sell 1,9153,552 held (−35%) $654.42 $1.3M +42.5%
Oct 31SEC REGNRegeneron Pharmaceuticals, Inc. Sell 1003,452 held (−3%) $655.10 $66K +42.4%
Oct 31SEC REGNRegeneron Pharmaceuticals, Inc. Sell 7122,740 held (−21%) $656.50 $467K +42.0%
Oct 31SEC REGNRegeneron Pharmaceuticals, Inc. Sell 3882,352 held (−14%) $657.29 $255K +41.9%
  • Sell

    Director Christine A Poon sold $3.1M of REGN at $969.50 — cuts the stake by 34%.

  • Sell

    Director Christine A Poon sold $1.8M of REGN at $653.50 — cuts the stake by 33%.

  • Sell

    Director Christine A Poon sold $1.3M of REGN at $654.42 — cuts the stake by 35%.

Follow Christine A. Poon

Get one email when Christine A. Poon files a new purchase or sale. Free.

At most one email a day about Christine A. Poon, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.